Established in 1991, MD Biosciences is a leading provider and expertise of preclinical, translational, and clinical phase services as well research products including, but not limited to, inflammatory and autoimmune diseases, neurology, oncology, pain, and metabolism.

Products, services, technology

MD Biosciences is a leading provider of preclinical, translational, clinical-phase contract research services and products for the development of pharmaceutical and diagnostic assets in therapeutic areas incl. inflammatory diseases, autoimmunity, neurology, oncology, metabolism, and pain.

Cooperation possibilities

Preclinical drug discovery services, biomarker and related assay development, clinical diagnostics services, histology/IHC services, in-licensing of proprietary markers, assays, antibodies and peptides.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    1991
  • Number of employees in Switzerland
    1-9